×
About 1,510 results

ALLMedicine™ Adrenocortical Carcinoma Center

Research & Reviews  587 results

ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP r...
https://doi.org/10.18632/aging.203534
Aging Wang L, Lyu Y et. al.

Sep 19th, 2021 - Adrenocortical carcinoma (ACC) is a rare but aggressive disease that lacks definitive treatment. We aim to evaluate role of ASXL1 in ACC and exploit its therapeutic merits therein. We performed in silico reproduction of datasets of the Cancer Geno...

Evaluation of Necrosis as a Diagnostic and Prognostic Indicator in Adrenocortical Carci...
https://doi.org/10.1001/jamasurg.2021.3646
JAMA Surgery; Pearlstein SS, Conroy PC et. al.

Sep 9th, 2021 - Evaluation of Necrosis as a Diagnostic and Prognostic Indicator in Adrenocortical Carcinoma.|2021|Pearlstein SS,Conroy PC,Menut KC,Kim J,Graves CE,|

Association between preoperative serum albumin and prognosis in patients with adrenocor...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393459
BMC Cancer; Zhang F, Liu Z et. al.

Aug 28th, 2021 - Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with a poor prognosis. Given the limited treatment options, prognostic assessment of ACC is increasingly crucial. In this study, we aim to assess the correlation between preoperati...

see more →

Guidelines  1 results

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an end...
https://doi.org/10.1210/jc.2008-0104
The Journal of Clinical Endocrinology and Metabolism; Funder JW, Carey RM et. al.

Jun 17th, 2008 - Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, si...

see more →

News  16 results

Urine Screen as Part of Triple Test Improves ID of Adrenal Cancer
https://www.medscape.com/viewarticle/934790

Jul 29th, 2020 - A strategy that includes a urine steroid test along with imaging characteristics and tumor size criteria can significantly improve the challenging diagnosis of adrenocortical cancer, helping to avoid unnecessary, and often unsuccessful, further im...

Adrenocortical Carcinoma Clinical Practice Guidelines (2018)
https://reference.medscape.com/viewarticle/904250

Nov 5th, 2018 - Clinical practice guidelines for the management of adrenocortical carcinoma in adults were released in October 2018 by the European Society of Endocrinology.[1] Diagnosis Perform a detailed hormonal workup of all patients with suspected adrenocort...

Adrenocortical Carcinoma Clinical Practice Guidelines (2018)
https://reference.staging.medscape.com/viewarticle/904250

Nov 5th, 2018 - Clinical practice guidelines for the management of adrenocortical carcinoma in adults were released in October 2018 by the European Society of Endocrinology.[1] Diagnosis Perform a detailed hormonal workup of all patients with suspected adrenocort...

New Clinical Practice Guidelines, August 2018 Edition
https://www.medscape.com/viewarticle/900291_6

Aug 9th, 2018 - Oncology Adrenocortical Carcinoma Advanced Breast Cancer Cancer Pain Management Constipation in Advanced Cancer HER2+ Advanced Breast Cancer

Resection of recurrence shows survival benefit for adrenocortical carcinoma
https://www.mdedge.com/internalmedicine/article/109105/pituitary-thyroid-adrenal-disorders/resection-recurrence-shows
Richard Mark Kirkner

May 25th, 2016 - BALTIMORE – Patients who have recurrent adrenocortical carcinoma appear to have one option to increase their survival: surgery that includes complete tumor resection – but it may a viable path only if the recurrence occurred a year or more after t.

see more →